Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab

Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab

Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation is a complication that often leads to graft loss. There is no consensus on the optimal treatment of recurrent FSGS. Rituximab, a monoclonal antibody to CD20, may be a useful treatment of this complication. Methods. W...

Full description

Saved in:
Bibliographic Details
Main Authors: Christine Sethna, Corinne Benchimol, Hilary Hotchkiss, Rachel Frank, Lulette Infante, Suzanne Vento, Howard Trachtman
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2011/389542
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items